Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

1,363 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Completed

Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer

NCT01462214

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Medisch Centrum Alkmaar Alkmaar, Netherlands
  • VU University Medical Center Amsterdam, Netherlands
  • NKI-AVL Amsterdam, Netherlands
  • Universitair Medisch Centrum Groningen Groningen, Netherlands
View all 13 locations
View Trial Details
Completed

Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer

NCT00425386

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Providence Cancer Center at Providence Portland Medical Center Portland, Oregon, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
  • Salem Hospital Salem, Oregon, United States
View Trial Details
Completed

Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II)

NCT01613846

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • A. ö. Bezirkskrankenhaus Kufstein Kufstein, Austria
  • AKH Linz GmbH Linz, Austria
  • LKH Salzburg Salzburg, Austria
View all 72 locations
View Trial Details
Completed

Warm Ischemia or Cold Ischemia During Surgery in Treating Patients With Stage I Kidney Cancer

NCT00743236

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
Locations
  • Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States
  • George Washington University Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • NYU Cancer Institute at New York University Medical Center New York, United States
View Trial Details

Related conditions